Finance

Beta
Lists
DACHF:OTCMKTS
Daicel Corp
$8.00
0.00%
(0.00) 1D
May 11, 2:45:59 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DACHF...
Mkt. cap
325.81B
Avg. vol.
4.00
Volume
0.00
52-wk high
$8.49
52-wk low
$8.00
Beta
0.47
Shares outstanding
256.14M
No. of employees
11K
Mkt. cap
325.81B
Avg. vol.
4.00
Volume
0.00
52-wk high
$8.49
52-wk low
$8.00
Beta
0.47
Shares outstanding
256.14M
No. of employees
11K
News stories
From sources across the web
Profile
Daicel Corporation is a chemical company based in Japan. It operates business in celluloid technologies, organic chemicals, high-performance chemicals, polymers and pyrotechnic devices. The company's products include cellulose acetate, tow for cigarette filters, high-performance chemicals, engineering plastics like liquid crystal polymers, resin compounds, and automotive airbag inflators. The company formed under the name of Dainippon Celluloid Company from a 1919 merger of eight regional celluloid manufacturers and changed its name to the present one in 1966. Its first subsidiary, Fuji Photo Film, was set up in 1934 to produce nitrocellulose film. Eventually this company became Fujifilm. As of early 2020, Daicel owned a majority stake in Polyplastics. By the end of 2020, Daicel purchased the remaining minority stake from Celanese and attained 100% ownership of Polyplastics. Wikipedia
About Daicel Corp
CEOYoshimi Ogawa
Employees11.2K
FoundedSep 8, 1919
HeadquartersOsaka, Osaka, Japan
SectorChemical industry
Websitedaicel.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
139.27B
137.85B
147.70B
154.80B
Cost of goods sold
99.31B
105.75B
109.93B
118.35B
Cost of revenue
99.31B
105.75B
109.93B
118.35B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.92B
25.02B
25.45B
26.83B
Operating expense
26.92B
25.02B
25.45B
26.83B
Total operating expenses
126.23B
130.77B
135.38B
145.18B
Operating income
13.04B
7.08B
12.32B
9.62B
Other non operating income
1.56B
-1.16B
-965.00M
869.00M
EBT including unusual items
13.56B
12.62B
24.84B
-24.85B
EBT excluding unusual items
13.57B
6.80B
12.29B
11.24B
Income tax expense
3.64B
3.37B
7.53B
183.00M
Effective tax rate
26.83%
26.68%
30.33%
-0.74%
Other operating expenses
-
-
-
-
Net income
9.62B
9.18B
16.90B
-25.52B
Net profit margin
6.91%
6.66%
11.44%
-16.49%
Earnings per share
-
-
-
-
Interest and investment income
684.00M
906.00M
709.00M
912.00M
Interest expense
-766.00M
-781.00M
-798.00M
-853.00M
Net interest expenses
-82.00M
125.00M
-89.00M
59.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
23.39B
17.29B
22.67B
20.46B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more